Detailed information for compound 305744

Basic information

Technical information
  • TDR Targets ID: 305744
  • Name: (2R)-2-[(3S,4S)-3-[[4-[5-[(4-chlorophenyl)met hyl]-2-ethylpyrazol-3-yl]piperidin-1-yl]methy l]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclo hexylacetic acid
  • MW: 621.227 | Formula: C36H46ClFN4O2
  • H donors: 1 H acceptors: 3 LogP: 5.37 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCn1nc(cc1C1CCN(CC1)C[C@H]1CN(C[C@@H]1c1cccc(c1)F)[C@H](C1CCCCC1)C(=O)O)Cc1ccc(cc1)Cl
  • InChi: 1S/C36H46ClFN4O2/c1-2-42-34(21-32(39-42)19-25-11-13-30(37)14-12-25)26-15-17-40(18-16-26)22-29-23-41(24-33(29)28-9-6-10-31(38)20-28)35(36(43)44)27-7-4-3-5-8-27/h6,9-14,20-21,26-27,29,33,35H,2-5,7-8,15-19,22-24H2,1H3,(H,43,44)/t29-,33+,35+/m0/s1
  • InChiKey: RTBAIVWNBSQJJO-HMQVCXRFSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (2R)-2-[(3S,4S)-3-[[4-[5-[(4-chlorophenyl)methyl]-2-ethyl-pyrazol-3-yl]-1-piperidyl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexyl-acetic acid
  • (2R)-2-[(3S,4S)-3-[[4-[5-[(4-chlorophenyl)methyl]-2-ethyl-3-pyrazolyl]-1-piperidinyl]methyl]-4-(3-fluorophenyl)-1-pyrrolidinyl]-2-cyclohexylacetic acid
  • (2R)-2-[(3S,4S)-3-[[4-[5-[(4-chlorophenyl)methyl]-2-ethyl-pyrazol-3-yl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexyl-ethanoic acid
  • (2R)-2-[(3S,4S)-3-[[4-[5-(4-chlorobenzyl)-2-ethyl-pyrazol-3-yl]piperidino]methyl]-4-(3-fluorophenyl)pyrrolidino]-2-cyclohexyl-acetic acid
  • (2R)-2-[(3S,4S)-3-[[4-[5-(4-chlorobenzyl)-2-ethyl-pyrazol-3-yl]-1-piperidyl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexyl-acetic acid
  • (2R)-[(3S,4S)-3-({4-[3-(4-Chlorobenzyl)-1-ethyl-1H-pyrazol-5-yl]piperidin-1-yl}methyl)-4-(3-fluorophenyl)pyrrolidin-1-yl](cyclohexyl)acetic acid
  • AIDS-193268
  • AIDS193268

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens chemokine (C-C motif) receptor 2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0051 0.7081 0.6633
Schistosoma mansoni tar DNA-binding protein 0.0065 1 1
Loa Loa (eye worm) pyruvate kinase 0.0034 0.3513 0.2518
Echinococcus granulosus tar DNA binding protein 0.0065 1 1
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0065 1 1
Echinococcus multilocularis pyruvate kinase 0.0027 0.1992 0.1992
Trypanosoma brucei pyruvate kinase 1, putative 0.0034 0.3513 0.5
Schistosoma mansoni tar DNA-binding protein 0.0065 1 1
Schistosoma mansoni pyruvate kinase 0.0034 0.3513 0.3513
Trichomonas vaginalis pyruvate kinase, putative 0.0034 0.3513 0.5
Trypanosoma cruzi pyruvate kinase 2, putative 0.0034 0.3513 0.5
Echinococcus multilocularis pyruvate kinase 0.0034 0.3513 0.3513
Trichomonas vaginalis pyruvate kinase, putative 0.0034 0.3513 0.5
Leishmania major pyruvate kinase 0.0034 0.3513 0.5
Loa Loa (eye worm) RNA binding protein 0.0065 1 1
Loa Loa (eye worm) pyruvate kinase 0.0034 0.3513 0.2518
Schistosoma mansoni tar DNA-binding protein 0.0065 1 1
Brugia malayi latrophilin 2 splice variant baaae 0.0035 0.3668 0.024
Onchocerca volvulus Pyruvate kinase homolog 0.0034 0.3513 0.5
Mycobacterium tuberculosis Probable pyruvate kinase PykA 0.0034 0.3513 0.5
Giardia lamblia Pyruvate kinase 0.0034 0.3513 1
Brugia malayi RNA recognition motif domain containing protein 0.0065 1 1
Entamoeba histolytica pyruvate kinase, putative 0.0024 0.1329 0.5
Brugia malayi Calcitonin receptor-like protein seb-1 0.0051 0.7081 0.55
Chlamydia trachomatis pyruvate kinase 0.0034 0.3513 0.5
Mycobacterium leprae Probable pyruvate kinase PykA 0.0034 0.3513 0.5
Onchocerca volvulus Pyruvate kinase homolog 0.0034 0.3513 0.5
Toxoplasma gondii pyruvate kinase PyK1 0.0034 0.3513 1
Schistosoma mansoni hypothetical protein 0.0035 0.3668 0.3668
Plasmodium falciparum pyruvate kinase 0.0034 0.3513 1
Brugia malayi TAR-binding protein 0.0065 1 1
Loa Loa (eye worm) hypothetical protein 0.0034 0.3513 0.2518
Echinococcus granulosus pyruvate kinase 0.0034 0.3513 0.3513
Echinococcus multilocularis tar DNA binding protein 0.0065 1 1
Mycobacterium ulcerans pyruvate kinase 0.0034 0.3513 0.5
Loa Loa (eye worm) pyruvate kinase 0.0034 0.3513 0.2518
Echinococcus multilocularis pyruvate kinase 0.0034 0.3513 0.3513
Schistosoma mansoni pyruvate kinase 0.0034 0.3513 0.3513
Schistosoma mansoni tar DNA-binding protein 0.0065 1 1
Plasmodium vivax pyruvate kinase, putative 0.0034 0.3513 1
Loa Loa (eye worm) TAR-binding protein 0.0065 1 1
Schistosoma mansoni tar DNA-binding protein 0.0065 1 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.3668 0.2698
Echinococcus granulosus pyruvate kinase 0.0034 0.3513 0.3513
Leishmania major pyruvate kinase 0.0034 0.3513 0.5
Trypanosoma brucei pyruvate kinase 1 0.0034 0.3513 0.5
Onchocerca volvulus Pyruvate kinase homolog 0.0034 0.3513 0.5
Trypanosoma cruzi pyruvate kinase 2, putative 0.0034 0.3513 0.5
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0051 0.7081 0.55
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0051 0.7081 0.6633

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.9 nM Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell ChEMBL. 15012999
IC50 (binding) = 0.9 nM Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell ChEMBL. 15012999
IC90 (functional) = 0.4 nM Antiviral activities in a cell culture HIV-1 infectivity inhibition assay using HeLa cells ChEMBL. 15012999
IC90 (functional) = 0.4 nM Antiviral activities in a cell culture HIV-1 infectivity inhibition assay using HeLa cells ChEMBL. 15012999
IC90 (functional) = 100 nM Antiviral activities in a cell culture HIV-1 infectivity inhibition assay using HeLa cells plus 50% normal human serum ChEMBL. 15012999
IC90 (functional) = 100 nM Antiviral activities in a cell culture HIV-1 infectivity inhibition assay using HeLa cells plus 50% normal human serum ChEMBL. 15012999

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.